The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  Teerawattananon, Yot ^a   Russell, Steve ^b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHOLECYSTECTOMY; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; GALLBLADDER DISEASE; HEALTH CARE POLICY; PUBLIC HEALTH SERVICE; RENAL REPLACEMENT THERAPY; SEMI STRUCTURED INTERVIEW; THAILAND; COMPARATIVE STUDY; COST; ECONOMICS; HEALTH SERVICES RESEARCH; HUMAN; INSURANCE; INTERVIEW; KIDNEY DISEASE; MANAGEMENT; ORGANIZATION; RESOURCE ALLOCATION; STATISTICAL MODEL;

CHOLECYSTECTOMY, LAPAROSCOPIC; COSTS AND COST ANALYSIS; DECISION MAKING, ORGANIZATIONAL; GALLBLADDER DISEASES; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE COVERAGE; INTERVIEWS AS TOPIC; KIDNEY DISEASES; MODELS, ECONOMIC; POLICY MAKING; RENAL DIALYSIS; RESOURCE ALLOCATION; THAILAND;

EID: 54049140350     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-197     Document Type: Article

References (35)

1. Rationing health care: an exploration. A Maynard, Health Policy 1999 49 1-2 5 11 10.1016/S0168-8510(99)00039-1 10827287
2. The role of economic evaluation in the pricing and reimbursement of medicines. M Drummond B Jonsson F Rutten, Health Policy 1997 40 3 199 215 10.1016/S0168-8510(97)00901-9 10168752
3. P Neumann, Using cost-effectiveness analysis to improve health care: opportunities and barriers Oxford: Oxford University Press 2005
4. Health Technology Assesssment Handbook. FB Kristensen M Horder PB Poulsen, Copenhagen: Denish Institute for Health Technology Assessment f 2001
5. Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards. A Szende Z Mogyorósy N Muszbek J Nagy G Pallos C Dózsa, HEPAC Health Economics in Prevention and Care 2002 3 3 196
6. NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales. A Gafni S Birch, PharmacoEconomics 2003 21 3 149 157 10.2165/00019053-200321030-00001 12558466
7. Health Economic Guidelines: Similarities, Differences and Some Implications. J Hjelmgren F Berggren F Andersson, Value Health 2001 4 3 225 250 10.1046/j.1524-4733.2001.43040.x 11705185
8. Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism? S Birch C Donaldson, Social Science & Medicine 2003 56 5 1121 1133 10.1016/S0277-9536(02)00101-6
9. Ethical issues in cost-effectiveness analysis. SD Pinkerton AP Johnson-Masotti A Derse PM Layde, Evaluation and Program Planning 2002 25 1 71 83 10.1016/S0149-7189(01)00050-7
10. Rationalising rationing: economic and other considerations in the debate about funding of Viagra. EA Stolk WB Brouwer JJ Busschbach, Health Policy 2002 59 1 53 63 10.1016/S0168-8510(01)00162-2 11786174
11. Common methodological flaws in economic evaluations. M Drummond M Sculpher, Med Care 2005 43 7 Suppl 5 14 16056003
12. Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries. A Harris M Buxton B O' Brien F Rutten M Drummond, Expert Review of Pharmacoeconomics & Outcomes Research 2001 1 1 7 12 10.1586/14737167.1.1.7
13. What Is Next for Pharmacoeconomics and Outcomes Research in Asia? J Doherty I Kamae KKC Lee H Li S-C Li GG Liu Y-H Tarn B-m Yang, Value Health 2004 7 2 118 132 10.1111/j.1524-4733.2004.72330.x 15164802
14. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. CP Iglesias MF Drummond J Rovira, Int J Technol Assess Health Care 2005 21 1 1 14 10.1017/S0266462305050014 15736509
15. Universal coverage and its impact on reproductive health services in Thailand. V Tangcharoensathien S Tantivess Y Teerawattananon N Auamkul P Jongudoumsuk, Reprod Health Matters 2002 10 20 59 69 10.1016/S0968-8080(02) 00087-3 12557643
16. Learning from Thailand's health reforms. A Towse A Mills V Tangcharoensathien, BMJ 2004 328 7431 103 105 14715608 10.1136/bmj.328.7431.103
17. Designing a reproductive health services package in the universal health insurance scheme in Thailand: match and mismatch of need, demand and supply. Y Teerawattananon V Tangcharoensathien, Health Policy Plan 2004 19 Suppl 1 i31 i39 10.1093/heapol/czh043 15452013
18. Universal health coverage in Thailand: ideas for reform and policy struggling. S Pannarunothai D Patmasiriwat S Srithamrongsawat, Health Policy 2004 68 1 17 30 10.1016/S0168-8510(03)00024-1 15033549
19. Is it worth offering a routine laparoscopic cholecystectomy in developing countries? a Thailand case study. Y Teerawattananon M Mugford, Cost Eff Resour Alloc 2005 3 1 10 16259625 10.1186/1478-7547-3-10
20. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Y Teerawattananon M Mugford V Tangcharoensathien, Value Health 2007 10 1 61 72 10.1111/j.1524-4733.2006.00145.x 17261117
21. Four unsolved rationing problems. A challenge. N Daniels, Hastings Cent Rep 1994 24 4 27 29 10.2307/3562841 7960702
22. Ethical issues in resource allocation, research, and new products development. D Brock D Wikler, Disease control priorities in developing countries New York: Oxford University Press and the World Bank, Jamison D, Breman JG, Measham AR, Alleyne G, Claeson M, Evan DB, Jha P, Mills A, Musgrove P, 2006 2
23. Medicaid participation by medical and surgical specialists. JB Mitchell, Med Care 1983 21 9 929 938 10.1097/00005650-198309000-00008 6353085
24. The appropriate uses of qualitative methods in health economics. J Coast, Health Econ 1999 8 4 345 353 10.1002/(SICI)1099-1050(199906)8:4<345::AID- HEC432>3.0.CO;2-Q 10398527
25. Issues arising from the use of qualitative methods in health economics. J Coast R McDonald R Baker, J Health Serv Res Policy 2004 9 3 171 176 10.1258/1355819041403286 15272976
26. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand. Y Teerawattananon S Russell, Value Health 2008 11 Suppl 1 S52 60 10.1111/j.1524-4733.2008.00367.x 18387068
27. Health Insurance Systems in Thailand: Major Research Questions. V Tangcharoensathien S Pitayarangsarit, Journal of Health Sciences 2003 12 2 159 168
28. P Ubel, Pricing life: why it's time for health care rationing Massachusetts: The MIT press 2000
29. Growth and Quality of the Cost-Utility Literature, 1976-2001. PJ Neumann D Greenberg NV Olchanski PW Stone AB Rosen, Value in Health 2005 8 1 3 9 10.1111/j.1524-4733.2005.04010.x 15841889
30. Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health Authorities. C Hoffmann BA Stoykova J Nixon JM Glanville K Misso MF Drummond, Value Health 2002 5 2 71 78 10.1046/j.1524-4733.2002.52109.x 11918822
31. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health care coverage decisions under the universal health insurance coverage scheme in Thailand. Y Teerawattananon S Russell, a paper submitted for publication in 'Value in Health' 2007
32. J Rawls, A theory of justice Oxford: Oxford University Press 1972
33. QALY maximisation and people's preferences: a methodological review of the literature. P Dolan R Shaw A Tsuchiya A Williams, Health Econ 2005 14 2 197 208 10.1002/hec.924 15386656
34. Choosing who shall not be treated in the NHS. MC Charny PA Lewis SC Farrow, Soc Sci Med 1989 28 12 1331 1338 10.1016/0277-9536(89)90352-3 2734629
35. V Tangcharoensathien V Kasemsup Y Teerawattananon T Supaporn V Chitpranee P Prakongsai, Universal access to renal replacement therapy in Thailand: A policy analysis Nonthaburi: International Health Policy Program & Nephrology Society of Thailand 2005